Cargando…
Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776760/ https://www.ncbi.nlm.nih.gov/pubmed/24058630 http://dx.doi.org/10.1371/journal.pone.0074809 |
_version_ | 1782284877386743808 |
---|---|
author | Yang, Xiaoping La Rosa, Francisco G. Genova, Elizabeth Erin Huber, Kendra Schaack, Jerome DeGregori, James Serkova, Natalie J. Li, Yuan Su, Lih-Jen Kessler, Elizabeth Flaig, Thomas W. |
author_facet | Yang, Xiaoping La Rosa, Francisco G. Genova, Elizabeth Erin Huber, Kendra Schaack, Jerome DeGregori, James Serkova, Natalie J. Li, Yuan Su, Lih-Jen Kessler, Elizabeth Flaig, Thomas W. |
author_sort | Yang, Xiaoping |
collection | PubMed |
description | The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate the effect of intravesical delivery on Cre recombination (Adeno-Cre), we examined activity and expression of β-galactosidase in the bladder of control ROSA transgenic mice. The results confirmed specific recombination as evidenced by β-galactosidase activity in the bladder urothelium of these mice. Then, we administered the same adenovirus into the bladder of double transgenic Kras(LSLG12D/+). p53(fl/fl) mice. The virus solution was held in place by a distal urethral retention suture for 2 hours. To our surprise, there was a rapid development of a spindle-cell tumor with sarcoma characteristics near the suture site, within the pelvic area but outside the urinary track. Since we did not see any detectable β-galactosidase in the area outside of the bladder in the validating (control) experiment, we interpreted that this sarcoma formation was likely due to transduction by Adeno-Cre in the soft tissue of the suture site. To avoid the loss of skin integrity associated with the retention suture, we transitioned to an alternative technique without suture to retain the Adeno-Cre into the bladder cavity. Interestingly, although multiple Adeno-Cre treatments were applied, only urothelial hyperplasia but not carcinogenesis was observed in the subsequent experiments of up to 6 months. In conclusion, we observed that the simultaneous inactivation of p53 and activation of Kras induces quick formation of spindle-cell sarcoma in the soft tissues adjacent to the bladder but slow formation of urothelial hyperplasia inside the bladder. These results strongly suggest that the effect of oncogene regulation to produce either hyperplasia or carcinogenesis greatly depends on the tissue type. |
format | Online Article Text |
id | pubmed-3776760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37767602013-09-20 Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia Yang, Xiaoping La Rosa, Francisco G. Genova, Elizabeth Erin Huber, Kendra Schaack, Jerome DeGregori, James Serkova, Natalie J. Li, Yuan Su, Lih-Jen Kessler, Elizabeth Flaig, Thomas W. PLoS One Research Article The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate the effect of intravesical delivery on Cre recombination (Adeno-Cre), we examined activity and expression of β-galactosidase in the bladder of control ROSA transgenic mice. The results confirmed specific recombination as evidenced by β-galactosidase activity in the bladder urothelium of these mice. Then, we administered the same adenovirus into the bladder of double transgenic Kras(LSLG12D/+). p53(fl/fl) mice. The virus solution was held in place by a distal urethral retention suture for 2 hours. To our surprise, there was a rapid development of a spindle-cell tumor with sarcoma characteristics near the suture site, within the pelvic area but outside the urinary track. Since we did not see any detectable β-galactosidase in the area outside of the bladder in the validating (control) experiment, we interpreted that this sarcoma formation was likely due to transduction by Adeno-Cre in the soft tissue of the suture site. To avoid the loss of skin integrity associated with the retention suture, we transitioned to an alternative technique without suture to retain the Adeno-Cre into the bladder cavity. Interestingly, although multiple Adeno-Cre treatments were applied, only urothelial hyperplasia but not carcinogenesis was observed in the subsequent experiments of up to 6 months. In conclusion, we observed that the simultaneous inactivation of p53 and activation of Kras induces quick formation of spindle-cell sarcoma in the soft tissues adjacent to the bladder but slow formation of urothelial hyperplasia inside the bladder. These results strongly suggest that the effect of oncogene regulation to produce either hyperplasia or carcinogenesis greatly depends on the tissue type. Public Library of Science 2013-09-18 /pmc/articles/PMC3776760/ /pubmed/24058630 http://dx.doi.org/10.1371/journal.pone.0074809 Text en © 2013 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yang, Xiaoping La Rosa, Francisco G. Genova, Elizabeth Erin Huber, Kendra Schaack, Jerome DeGregori, James Serkova, Natalie J. Li, Yuan Su, Lih-Jen Kessler, Elizabeth Flaig, Thomas W. Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title | Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title_full | Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title_fullStr | Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title_full_unstemmed | Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title_short | Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia |
title_sort | simultaneous activation of kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776760/ https://www.ncbi.nlm.nih.gov/pubmed/24058630 http://dx.doi.org/10.1371/journal.pone.0074809 |
work_keys_str_mv | AT yangxiaoping simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT larosafranciscog simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT genovaelizabetherin simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT huberkendra simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT schaackjerome simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT degregorijames simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT serkovanataliej simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT liyuan simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT sulihjen simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT kesslerelizabeth simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia AT flaigthomasw simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia |